Suchergebnisse - "O'Day, Steven J"

PubPharm (5)

1

Prospective Molecular Profiling of Circulating Tumor Cells from Patients with Melanoma Receiving Combinatorial Immunotherapy

enthalten in: Clinical chemistry | 2020

von Lin, S. | Chang, S. | Lam, S. | +11

2

Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2014

von Falchook, G. | Long, G. | Kurzrock, R. | +15

3

Clinical and pharmacologic evaluation of two dose levels of intetumumab (CNTO 95) in patients with melanoma or angiosarcoma

enthalten in: Investigational new drugs | 2012

von O'Day, S. | Pavlick, A. | Albertini, M. | +7

4

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours : a phase 1 dose-escalation trial

enthalten in: Lancet (London, England) | 2012

von Falchook, G. | Long, G. | Kurzrock, R. | +14

CommentIn: Lancet. 2012 May 19;379(9829):1858-9. - PMID 22608322

5

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

enthalten in: The New England journal of medicine | 2011

von Chapman, P. | Hauschild, A. | Robert, C. | +126

CommentIn: N Engl J Med. 2011 Jun 30;364(26):2547-8. - PMID 21639809

1
[1]